distension, are encountered in at least 50-75 percent of patients presenting with diabetic ketoacidosis (DKA) [1, 2] . Not uncommonly, these symptoms dominate the clinical picture at the time of initial presentation, leading, in some cases, to a delay in treatment with fluids and insulin. On rare occasions, uncomplicated DKA may be accompanied by physical signs suggestive of an acute surgical abdomen [3] . In some instances, unnecessary hazardous surgical intervention has been undertaken, particularly in the previously undiagnosed diabetic [4] . Since in the vast majority of cases the gastrointestinal manifestations of DKA resolve spontaneously with appropriate treatment of the metabolic disturbance, it is incumbent on the clinician to distinguish gastrointestinal symptoms resulting from DKA per se from those caused by an active intra-abdominal process (e.g., cholecystitis, peritonitis, vascular compromise, or pancreatitis).
In this regard, it should be emphasized that fatalities from DKA most often result from underlying non-diabetic medical and/or surgical emergencies which may go unrecognized due to the severity of the metabolic abnormalities or its depressive effects on mental function [5] . Consequently, it is critical not to overlook a potentially treatable abdominal crisis.
Of common reversible gastrointestinal symptoms associated with ketoacidosis, the nausea and vomiting have been attributed to either a central neurogenic response to the ketoacidosis, gastric atony, generalized ileus, gastritis, or pancreatitis [2] . The latter two processes, and rapid expansion of the hepatic capsule, presumably secondary to fatty engorgement of the liver, have been invoked to explain the abdominal pain that so frequently accompanies ketoacidosis (6] . However, largely because these symptoms resolve promptly with fluid and insulin therapy, their pathogenesis remains unclear. It is of interest to note that the entire clinical picture of profound nausea, epigastric pain, and repeated vomiting can be induced in the well-controlled diabetic by withdrawing insulin therapy [7] and reversed with restoration of insulin and fluid replacement. It is possible that the increased circulating levels of glucagon and catecholamines or other hormones accompanying ketoacidosis impede gastrointestinal motility. Even hyperglycemia per se has been implicated in inhibiting gastric emptying [8] . Whether insulin deficiency itself, or the altered metabolic milieu (ketonemia, hyperglycemia, acidosis, and dehydration) associated with insulin deprivation, is responsible for the gastrointestinal symptoms remains unresolved. The awareness that decompensated diabetes may produce episodes of nausea, vomiting, or abdominal pain should lead the physician to evaluate the metabolic control in any known diabetic with these symptoms.
If, by a combination of clinical and laboratory examination, a diagnosis of ketoacidosis is established in a patient with significant gastrointestinal complaints, the physician must recognize that acute cholecystitis [9] , acute pancreatitis [2] , and mesenteric vascular insufficiency all occur with increased frequency in the diabetic [2] . Furthermore, development of any severe intra-abdominal process may be sufficient stress to cause decompensation of previously well-controlled diabetes and precipitate an episode of DKA. The need for accurate and timely diagnosis is underlined by the mortality observed when ketoacidosis is complicated by either acute pancreatitis [2] or acute cholecystitis [9] . Fortunately [10, 11] . Macroamylasemia is not responsible for this increase in serum amylase, and isozyme studies suggest that salivary as well as pancreatic amylase elevations occur in DKA. The renal amylase to creatinine clearance ratio can also be raised during ketoacidosis, in the absence of the clinical picture of acute pancreatitis [8] . In the 21 patients with hyperamylasemia during DKA reported by Knight et al. [10] none had severe back pain or abdominal rigidity, features frequently encountered in patients with acute pancreatitis. These authors further comment that serum lipase activity did not correlate with serum amylase in their patients and was frequently normal or only modestly elevated in the face of striking increases in serum amylase. In summary, it appears that an elevated serum amylase concentration cannot be considered as definitive evidence for clinically significant pancreatic inflammation in the absence of concomitant elevation in serum lipase levels and suggestive physical findings.
Abnormal values for SGOT, SGPT, LDH, and other liver enzymes have been reported to occur frequently in patients admitted in ketoacidosis. Knight has reported mild to marked elevations of hepatic enzymes in 33 percent of 36 episodes of ketoacidosis [12] . In approximately half of these cases, some underlying disease of the hepato-biliary tree was sufficient to explain the abnormal serum enzyme pattern, while in the remaining patients no specific cause for the abnormal liver enzyme pattern could be identified. As with amylase, no significant correlation existed between the serum levels of hepatic enzymes and the presence or severity of abdominal symptoms. It has been suggested that in these cases reversible hepatocellular damage, sufficient to allow release of cytosolic enzymes, occurs during the development of ketoacidosis. Fatty infiltration of the liver and reduced hepatic perfusion may contribute to this process.
This discussion of the difficulties involved in the laboratory diagnosis of abdominal pathology in ketoacidotic patients with gastrointestinal symptoms serves to underline again the importance of history and physical examination in the evaluation of these patients. When the duration of severity of gastrointestinal symptoms or the physical findings lead the physician to suspect an intra-abdominal inflammatory process, early surgical consultation and further diagnostic evaluation should be undertaken as dictated by the clinical situation (e.g., paracentesis, endoscopy, etc.). The abdominal pain, nausea, and vomiting which occur secondary to diabetic acidosis alone resolve with improvement of the metabolic picture. Thus, when the gastrointestinal symptoms persist beyond the first 12 to 24 hours after beginning treatment of DKA, additional etiologies should be actively sought. Finally, it should be emphasized that the presence of DKA should not lead to unnecessary delays when immediate surgical intervention is indicated. As soon as fluid deficits are for the most part replaced and acidosis is corrected (usually within four to six hours) the required surgical procedures may be undertaken. Frequent assessment of serum glucose and electrolytes and of fluid balance must continue through the operative and post-operative period. This information will allow appropriate insulin and fluid replacement and avoid the complications of hypoglycemia, hypokalemia, or recrudescence of acidosis.
